<<Prev Rule

Texas Administrative Code

Next Rule>>
TITLE 22EXAMINING BOARDS
PART 9TEXAS MEDICAL BOARD
CHAPTER 198STANDARDS FOR USE OF INVESTIGATIONAL AGENTS
SUBCHAPTER BINVESTIGATIONAL STEM CELL TREATMENTS FOR PATIENTS WITH CERTAIN SEVERE CHRONIC DISEASES OR TERMINAL ILLNESSES
RULE §198.5Use of Investigational Stem Cell Treatments for Patients with Certain Severe Chronic Diseases or Terminal Illnesses

(a) The Legislature recognizes the need for patient access to innovative medical treatments. At the same time, the health and welfare of Texas citizens must be protected. These goals must be carefully balanced.

(b) The purpose of this subchapter is to set out the requirements for a patient to be eligible for consideration of receiving investigational stem cell treatment and under what circumstances a certified physician may administer or provide investigational stem cell treatments. The implementation of this rule is contingent upon qualifying chronic diseases or terminal illness being defined, as set out in §1003.052 of the Texas Health and Safety Code.

(c) This rule does not require an eligible patient to receive such treatment, but rather the statute sets the eligibility standards and the parameters under which treatment may be provided to an individual with a qualifying severe chronic disease or terminal illness.

(d) Stem cell treatments which are under investigation in a clinical trial and being administered to human participants:

  (1) may be administered or provided to eligible patients with qualifying terminal illnesses or severe chronic diseases as defined by the executive commissioner of the Health and Human Services Commission; and

  (2) must be done in compliance with applicable law.

(e) In order for a patient to be eligible to receive treatment with investigational stem cells, the eligible patient must:

  (1) be enrolled in a clinical trial investigating the use of adult stem cells in humans;

  (2) sign a written informed consent, before receiving treatment, which includes documentation of compliance with §1003.053(2)(a) of the Texas Health and Safety Code;

  (3) receive treatment from a physician certified under §1003.055 of the Texas Health and Safety Code by:

    (A) a qualifying IRB;

    (B) a medical school as defined by §61.501 of the Education Code; or

    (C) a hospital licensed under Chapter 241 of the Texas Health and Safety Code; and

  (4) receive treatment in a qualifying facility under §1003.055 of the Texas Health and Safety Code.


Source Note: The provisions of this §198.5 adopted to be effective July 19, 2018, 43 TexReg 4754

Link to Texas Secretary of State Home Page | link to Texas Register home page | link to Texas Administrative Code home page | link to Open Meetings home page